Medications Development Program Projects for Substance Related Disorders (P01) | Apply Online

Opportunity Summary:

The Medications Development Program Projects for Substance Related Disorders (P01) opportunity (Funding Opportunity Number RFA-DA-12-005) is a National Institutes of Health grant announcement from the National Institute on Drug Abuse (NIDA) aimed at accelerating the discovery and development of therapeutics for substance related disorders (SRDs). The core idea is to fund investigator-initiated, team-based translational programs that can move potential treatments forward in a coordinated way, using shared resources and a unified scientific direction rather than isolated, single-project efforts.

This FOA uses the P01 program project grant mechanism, which is built around a central theme that ties multiple projects together into one coherent program. Applicants are expected to propose a set of closely related studies that benefit from collaboration, shared facilities, common instrumentation, and coordinated management. At the same time, each component research project must stand on its own scientifically; reviewers evaluate the merit of each project independently and also judge how well the projects function together as an integrated program. In practical terms, the application needs to show both strong individual projects and a convincing argument that the combined program achieves more than the projects would achieve separately.

NIDA designed this initiative specifically to support translational research programs composed of at least three interrelated projects, which can be preclinical, clinical, or a mix of both. The emphasis on translation signals an interest in work that connects basic discovery to therapy development, such as identifying or validating targets, optimizing candidate compounds or biologics, developing and testing medication strategies, advancing promising interventions through preclinical efficacy and safety studies, and moving into early-stage clinical evaluation when appropriate. The FOA is open to development of both new therapeutics and new uses or improved versions of existing therapeutics, as long as the work is clearly positioned to advance treatment options for SRDs.

The announcement also encourages applicants to build synergistic collaborations with industry to strengthen the real-world development potential of the proposed therapeutics work. This reflects a practical focus: medication development often benefits from partners who can contribute specialized expertise, manufacturing capacity, regulatory experience, intellectual property strategy, or pathways to later-stage development and commercialization. While industry partnerships are not framed as a strict requirement, the FOA highlights them as a way to increase the likelihood that discoveries can progress into usable treatments.

In terms of structure and management, the FOA makes clear that coordination is essential. An Administrative Core or other shared cores are optional, but the expectation is that the Program Director/Principal Investigator (PD/PI), or a multi-PI coordinating group, will actively manage the overall program, ensure communication across projects, and keep the different components aligned with the central theme and milestones. Because the P01 mechanism is fundamentally collaborative, applicants need to show how the program will operate day to day, how decisions will be made, and how shared resources will be used efficiently across the projects.

Substantively, NIDA allows program projects to focus on essentially any novel treatment strategy for SRDs involving cocaine, methamphetamine, cannabis, nicotine, or opioids. That breadth leaves room for a wide range of therapeutic modalities and approaches, provided the overall program is cohesive and development-focused. The grant is categorized under Health and Education, and it falls under CFDA number 93.279 (Drug Abuse and Addiction Research Programs). It does not require cost sharing or matching funds.

Eligibility is broad and includes many organization types such as public and private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (including small businesses), and a range of government entities (state, county, city/township, special districts), tribal governments and tribal organizations, public housing authorities/Indian housing authorities, and other groups described in the FOA. The eligibility notes explicitly include institutions such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations, among others. Foreign (non-U.S.) components of U.S. organizations are not allowed under this announcement.

Key administrative details from the posting indicate the FOA was posted March 29, 2011, with an original and current closing date of July 29, 2011, and an archive date of August 29, 2011. The estimated total funding listed is $3,000,000. The official information and full announcement were provided through NIH’s grants site (link included in the source), and NIH’s Office of Extramural Research (OER) webmaster contact was provided for access or linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Early detection of Invasive Plans

Previous opportunity: Interpretive programs and volunteer coordination

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 12 005

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 12 005) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 12 005", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.